(PharmaNewsWire.Com, April 21, 2019 ) Radiopharmaceuticals, or medicinal radiocompounds or nuclear medicines, are a group of pharmaceutical drugs which have radioactivity. These nuclear medicines can be used for diagnostic as well as therapeutic applications. Radiopharmaceuticals emit radiation themselves, which is different from contrast media which absorb or alter external electromagnetism or ultrasound. Radiopharmacology is the branch of pharmacology that specializes in these radiocompounds. The main group of these compounds are the radiotracers used to diagnose dysfunction in body tissues. While not all medical isotopes are radioactive, radiopharmaceuticals are the oldest and still most common such drugs.
MARKET DYNAMICS The radiopharmaceuticals market is anticipated to grow in the forecast, owing to the factors such increasing incidence and prevalence of target conditions, alpha radioimmunotherapy-based targeted cancer treatment and initiatives to lessen the demand-supply gap of Mo-99 in the market during the forecast period. However short life of the radiopharmaceuticals is hampering the market growth.
MARKET SCOPE The "Global Radiopharmaceuticals Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of radiopharmaceuticals market with detailed market segmentation by applications, end user and geography. The global radiopharmaceuticals market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading radiopharmaceuticals market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION The global radiopharmaceuticals market is segmented on the basis of applications and end user and geography. Based on application, the market is segmented as diagnostic applications and therapeutic applications. On the basis of end user, the global radiopharmaceuticals market is segmented into, hospitals and diagnostic centers.
REGIONAL FRAMEWORK The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global radiopharmaceuticals market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The radiopharmaceuticals market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting radiopharmaceuticals market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the radiopharmaceuticals market in these regions.
Global Radiopharmaceuticals Market - By Geography
North America U.S. Canada Mexico
Europe Uk Germany France
Asia Pacific (Apac) Japan China India
Middle East & Africa (Mea) U.A.E Saudi Arabia South Africa
Several Important Key Questions Answer Covered In This Radiopharmaceuticals Market Research Report:
What Is Radiopharmaceuticals Market Forecasts (2019-2027)? – Considering Sales, Revenue, Growth Rate, Price And Trends For Regions, Types And Applications? What Is Status Of Radiopharmaceuticals Market? -This Overview Includes Analysis Of Scope, Prospect And Growth Trend, Sales By Regions, Manufacturers, Types And Applications. What Trends, Challenges And Barriers Are Influencing Its Growth? Who Are Radiopharmaceuticals Market Key Manufacturers? What Will Be The Market Size And The Growth Rate In 2027? -What Are The Key Factors Driving The Global Radiopharmaceuticals Market? What Are The Key Outcomes Of The Distinct Analysis Of The World Radiopharmaceuticals Market-Analysis Done By Considering Prime Elements?
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
